Victoria Vakiener, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 20,080 shares at $66.63 ($1.4M) on 2025-12-19, disclosed to the SEC on 2025-12-23.
Scheduled sale ($1.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.63 | 2,799 | $186K | 13.7% |
| 2 | $66.63 | 2,799 | $186K | 13.7% |
| 3 | $67.97 | 5,281 | $359K | 26.4% |
| 4 | $67.97 | 5,281 | $359K | 26.4% |
| 5 | $68.39 | 1,960 | $134K | 9.9% |
| 6 | $68.39 | 1,960 |
| $134K |
| 9.9% |
| Total | $67.68 avg | 20,080 | $1.4M | 100% |
| Filing → |
| ARWR | SELL | 2024-01-16 | $317K | — | Filing → |
| ARWR | SELL | 2023-10-02 | $41K | — | Filing → |
| EPZM | SELL | 2021-02-05 | $9K | — | Filing → |